Fairvalue-Calculator Fairvalue-Calculator
EN DE

MGI Tech Co (688114) Fair Value & Analysis

Healthcare · CN · Market cap 21.6B CNY

Price¥50.69
Fair Value¥82.62
Upside+63.0%
Quality95/100
Evidence: Medium Range ¥61.97 – ¥103.28

Fair value as of: Jun 24, 2026

Analysis

MGI Tech Co (688114) currently trades at ¥50.69, while our model-based Fair Value estimate is ¥82.62 — implying the stock looks roughly 63.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing platforms; novel products, including STOmics, cell omics, ultrasound, BIT, and sample storage products, as well as microneedling products. MGI Tech Co., Ltd. was founded in 2016 and is headquartered in Shenzhen, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is MGI Tech Co (688114) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥82.62 versus a price of ¥50.69 — about +63% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 688114?
Our 21-model fair value for MGI Tech Co is ¥82.62 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥50.69.
What is the quality score of 688114?
MGI Tech Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.